Home LiteratureArticle Details
PMID: 2786510 Published · ppublish English Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S.

The prevalence of antibody to p42 of HTLV-I among ATLL patients in comparison with healthy carriers in Japan.

International journal of cancer ·Vol. 43 ·No. 6 ·1989-06-15 ·Pages 970-4

Yokota T, Cho MJ, Tachibana N, McLane MF, Takatsuki K, Lee TH, Mueller N, Essex M

Abstract

A gene product (p42) of the long open reading frame, now termed tax, of the viral genome of human T-cell leukemia virus type I (HTLV-I) may be related to the transformation of T cells in adult T-cell leukemia-lymphoma (ATLL). To evaluate its association with the disease, we compared the prevalence of antibody to p42 in sera obtained from 105 HTLV-I carriers and 64 ATLL patients from southwest Japan. The prevalence of the anti-p42 antibody reactivity was 63% among carriers and 31% among cases. The cases were more than 3 times as likely to lack antibody to p42 than carriers, the relative odds (OR) = 3.4, p = 0.001. When the samples were tested for antibody against p24, the most immunogenic core protein, the prevalence was somewhat higher among carriers (65%) than in cases (52%), but not significantly so (p = 0.15). Among the healthy carriers, the correlation between the prevalence of both antibodies was high (p = 0.001), and only 25% of those who had antibody to p24 lacked antibody to p42. However, among the cases, reactivity to both antigens was independent (p = 0.52), and 65% of those with antibody to p24 lacked antibody to p42, OR = 6.3, p = 0.0004. Thus the strongest serologic marker of ATLL following diagnosis was lack of reactivity to p42, particularly among those subjects with anti-p24. Whether this altered response is present prior to disease remains to be determined.

MeSH Terms
Autoradiography Carrier State/epidemiology,immunology Electrophoresis, Polyacrylamide Gel Female HTLV-I Antibodies/analysis HTLV-I Antigens/analysis,immunology Humans Japan Leukemia-Lymphoma, Adult T-Cell/epidemiology,immunology Male Middle Aged Precipitin Tests Trans-Activators Transcription Factors/analysis,immunology
Chemicals
HTLV-I Antibodies HTLV-I Antigens Trans-Activators Transcription Factors
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Yokota T
Department of Cancer Biology, Harvard School of Public Health, Boston, MA 02115.
Cho M J
Tachibana N
McLane M F
Takatsuki K
Lee T H
Mueller N
Essex M
Article Info
Journal
International journal of cancer
Abbr.
Int J Cancer
ISSN
0020-7136
Published
1989-06-15
Pages
970-4
Language
English
Region
United States
NLM ID
0042124
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com